Underuse of brachytherapy for the treatment of dysphagia owing to esophageal cancer. An Italian survey
International guidelines strongly recommend brachytherapy as valid alternative or in addition to stenting in patients with dysphagia owing to esophageal cancer. However, for not well understood reasons, brachytherapy is definitively underused for the palliative treatment of malignant dysphagia. Aim of the current survey was to investigate the use of brachytherapy for the treatment of malignant dysphagia in Italy.
Source: Digestive and Liver Disease - Category: Gastroenterology Authors: Lorenzo Fuccio, Alessandra Guido, Cesare Hassan, Leonardo Frazzoni, Alessandra Arcelli, Andrea Farioli, Lucia Giaccherini, Andrea Galuppi, Daniele Mandolesi, Francesco Cellini, Giovanna Mantello, Gabriella Macchia, Nicola de Bortoli, Alessandro Repici, Vi Tags: Oncology Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | Esophagus Cancer | Gastroenterology | Liver | Liver Disease | Palliative | Palliative Care | Urology & Nephrology